Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents

Transplant Immunology

Volumn 28, Issue 2-3, 2013, Pages 86-92

  Hong, Juho ^a   Yeom, Hye Jung ^a   Lee, Eunwon ^a   Han, Kyu Hyun ^a   Koo, Tai Yeon ^a,b   Cho, Bumrae ^a   Ro, Han ^c   Oh, Kook Hwan ^b   Ahn, Curie ^a,b   Yang, Jaeseok ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Gachon University   (South Korea)

Author keywords

5 Azacytidine; IL 2 anti IL 2 complex; Islet transplantation; Memory; Sensitization

Indexed keywords

AZACITIDINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 COMPLEX; MR 1; RAPAMYCIN; RM 134L; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL MEMORY; ISLET ALLOGRAFT REJECTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION;

EID: 84879795442     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.01.005     Document Type: Article

References (15)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen. N Engl J Med 2000;343:230-8.
2. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-9.
3. Campbell PM, Salam A, Ryan EA, Senior P, Paty BW, Bigam D, et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 2007;7:1242-8.
4. Campbell PM, Senior PA, Salam A, Labranche K, Bigam DL, Kneteman NM, et al. High risk of sensitization after failed islet transplantation. Am J Transplant 2007;7:2311-7.
5. Valujskikh A. Targeting T-cell memory: where do we stand? Curr Opin Organ Transplant 2008;13:344-9.
6. Yang J, Brook MO, Carvalho-Gaspar M, Zhang J, Ramon HE, Sayegh MH, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A 2007;104:19954-9.
7. Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, et al. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Diabetes 2001;50:270-6.
8. Porrett PM, Yuan X, LaRosa DF, Walsh PT, Yang J, Gao W, et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 2008;181: 1692-9.
9. Vu MD, ClarksonMR, Yagita H, Turka LA, Sayegh MH, Li XC. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 2006;176:1394-401.
10. Xia J, Chen J, Shao W, Lan T, Wang Y, Xie B, et al. Suppressing memory T cell activation induces islet allograft tolerance in alloantigen-primed mice. Transpl Int 2010;23:1154-63.
11. Lunsford KE, Gao D, Eiring AM, Wang Y, Frankel WL, Bumgardner GL. Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity. Transplantation 2004;78:1125-33.
12. Choi J, Ritchey J, Prior JL, Holt M, Shannon WD, Deych E, et al. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood 2010;116:129-39.
13. Sanchez-Abarca LI, Gutierrez-Cosio S, Santamaria C, Caballero-Velazquez T, Blanco B, Herrero-Sanchez C, et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood 2010;115:107-21.
14. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 2009;206:751-60.
15. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 2006;311: 1924-7.